Pharmacologic treatment for postviral olfactory dysfunction: a systematic review

@article{Harless2016PharmacologicTF,
  title={Pharmacologic treatment for postviral olfactory dysfunction: a systematic review},
  author={Lucas D. Harless and Jonathan Liang},
  journal={International Forum of Allergy \& Rhinology},
  year={2016},
  volume={6},
  pages={760 - 767}
}
Postviral olfactory dysfunction (PVOD) is the most common cause of olfactory dysfunction. Several treatments have been presented in the literature. The objective of this study is to systematically review the existing literature on the effectiveness of pharmacologic treatments for PVOD. 
Treatment of post‐viral olfactory dysfunction: an evidence‐based review with recommendations
TLDR
A comprehensive review of PVOD treatment options is provided and evidence‐based recommendations for their use are provided.
Therapeutic use of steroids in non–chronic rhinosinusitis olfactory dysfunction: a systematic evidence‐based review with recommendations
TLDR
This study systematically reviews the literature on the efficacy of steroids for non–chronic rhinosinusitis (CRS)‐related olfactory loss and provides recommendations.
A special symptom of olfactory dysfunction in coronavirus disease 2019: report of three cases
TLDR
Olfactory disorders are uncommon symptoms of coronavirus disease (COVID-19) in China and particular attention should be devoted to olfactory dysfunction.
Olfactory Training for Postviral Olfactory Dysfunction: Systematic Review and Meta-analysis
TLDR
Meta-analysis of existing data demonstrates clinically significant improvements in PVOD associated with OT, and existing data supports the use of OT for the treatment of existing and newly emerging cases of PVOD.
Treatment of Postinfectious Olfactory Dysfunction Using Corticosteroids.
TLDR
Different doses and forms of corticosteroids showed no significant difference in the therapeutic effect on postinfectious olfactory dysfunction, but the o aroma discrimination threshold at the first consultation was the most important factor influencing the prognosis.
Pharmacologic therapy of olfaction disroders induced by COVID-19 upper respiratory infection
TLDR
Olfactory training is a safe option without side effects that can be used for treating olfactory disorders caused by upper respiratory tract infections and further rigorous studies are needed to determine the efficacy of the combination of drug treatment and ofactory training.
Pathophysiological mechanisms and management of patients with long‐time anosmia related to COVID‐19
TLDR
As stated by authors, the development of anosmia is related to the infection of the sustentacular and basal cells, which highly express ACE-2.
MANEJO TERAPÊUTICO DO PACIENTE COM DISFUNÇÃO OLFATÓRIA: REVISÃO DA LITERATURA
TLDR
Olfactory dysfunction has been shown to be a very prevalent alteration in patients with COVID-19, both as a clinical presentation and as a sequel of duration not yet determined, and how the new publications on the treatment of hyposmia and anosmia have brought therapeutic opportunities is sought.
What to propose to treat post-viral non-conductive smell disorder in COVID-19? - systematic review with meta-analysis
TLDR
Olfactory training and sodium citrate are therapeutic approaches to recover olfactory function in post-viral NCSD and can be considered considered for N CSD due to COVID-19; however, further clinical trials are needed to confirm the results evaluated and establish treatment protocols.
International consensus statement on allergy and rhinology: Olfaction
TLDR
Experts from around the world have gathered to produce the International Consensus on Allergy and Rhinology: Olfaction (ICAR:O), which aims to consolidate and critically review the evidence on clinical olfaction.
...
1
2
3
...

References

SHOWING 1-10 OF 16 REFERENCES
Treatment of postinfectious olfactory disorders with minocycline: A double‐blind, placebo‐controlled study
TLDR
Treatment with the antibiotic minocycline, which has been shown to act as an antiapoptotic agent, is thought to accelerate improvement of olfactory function.
Use of olfactory training in post‐traumatic and postinfectious olfactory dysfunction
TLDR
The aim of this study was to assess the effectiveness of olfactory training in patients with postinfectious and post‐traumatic Olfactory dysfunction.
Olfactory function in patients with postinfectious and posttraumatic smell disorders before and after treatment with vitamin A: A double‐blind, placebo‐controlled, randomized clinical trial
TLDR
In this study, the effectiveness of vitamin A in postinfectious and posttraumatic smell disorders is investigated and it is likely due to the stimulation of regeneration and repair of the peripheral olfactory system.
Lipoic Acid in the Treatment of Smell Dysfunction Following Viral Infection of the Upper Respiratory Tract
TLDR
Investigation of the potential therapeutic effects of α‐lipoic acid in olfactory loss following infections of the upper respiratory tract found possible mechanisms of actions include the release of nerve growth factor and antioxidative effects, both of which may be helpful in the regeneration of Olfactory receptor neurons.
Treatment of postviral olfactory loss with glucocorticoids, Ginkgo biloba, and mometasone nasal spray.
TLDR
Although the treatment response was not statistically different between the monotherapy group and the combination therapy group, the addition of G biloba showed a tendency of greater efficacy in the treatment of postviral olfactory loss.
Treatment of smell loss with systemic methylprednisolone.
TLDR
This study confirms the effectiveness of systemic corticosteroids on olfactory dysfunction in a large patient population and shows that treatment is most effective in patients with sinunasal disease with nasal polyps and at best, effective in half of the patients.
Modified olfactory training in patients with postinfectious olfactory loss
TLDR
This prospective study investigated whether the effect of OT might increase through the use of more odors and extension of the training period.
Post-infectious olfactory dysfunction exhibits a seasonal pattern.
TLDR
Post-URTI olfactory dysfunction exhibits spring seasonality with peaks in March and May and possible causative factors being influenza and parainfluenza viruses (type III), respectively.
Effect of zinc sulfate on sensorineural olfactory disorder.
TLDR
The difference between post-traumatic and post-viral olfactory disorders in the effect of zinc sulfate therapy appeared to depend on the pathology of the associated lesions.
The Quinoxaline Derivative Caroverine in the Treatment of Sensorineural Smell Disorders: a Proof-of-Concept Study
TLDR
Results indicate that caroverine appears to be effective for the treatment of non-conductive smell disorders and significantly improved odor identification ability in anosmic patients and in hyposmic patients.
...
1
2
...